Obesity drugs
Zealand Pharma’s stock swings show weight-loss drug market’s new test
Survodutide’s dropout rates cooled enthusiasm, but investors are watching whether amylin-based petrelintide can offer a more tolerable obesity treatment
Weight loss drugs news
Read verified news on BetaVoices covering Weight loss drugs, with reporting, context, and related developments.
#Weight loss drugs
Clear filters
- Obesity drugs Zealand Pharma shares tumble as safety data hit drug hopes Survodutide met late-stage trial goals, but gastrointestinal side effects and a 19% dropout rate raised doubts about its commercial potential
- Weight-loss drugs GLP-1 hair shedding fuels a growing beauty market As use of weight-loss drugs rises, brands and retailers are seeing more demand for scalp treatments, supplements and products aimed at thinning hair